Drug Manufacturers - General Industry Overview
The Drug Manufacturers - General industry, part of the Healthcare sector, includes 21 publicly traded companies with a combined market capitalization of $3.82T. The industry is led by Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV).
Among the 21 listed Drug Manufacturers - General companies, market capitalizations range from $949.47B (Eli Lilly and Company) down to $290.30B (AstraZeneca PLC), highlighting the wide size disparity across the industry. The average market cap across the industry is $182.01B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Drug Manufacturers - General Industry Valuation
The Drug Manufacturers - General industry currently trades at an average price-to-earnings (P/E) ratio of 26.3. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - General companies.
Drug Manufacturers - General Dividend Profile
15 out of 21 Drug Manufacturers - General companies (71%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - General stocks is 3.07%. The high proportion of dividend payers suggests Drug Manufacturers - General is a mature, cash-generating industry that rewards income-focused investors.
Largest Drug Manufacturers - General Companies by Market Cap
| Company | Ticker | Market Cap | P/E Ratio |
|---|---|---|---|
| Eli Lilly and Company | LLY | $949.47B | 37.9 |
| Johnson & Johnson | JNJ | $554.09B | 26.7 |
| AbbVie Inc. | ABBV | $376.54B | 104.0 |
| Merck & Co., Inc. | MRK | $302.33B | 34.5 |
| AstraZeneca PLC | AZN | $290.30B | 28.1 |
The table above shows the top 5 Drug Manufacturers - General companies ranked by market capitalization. P/E ratios reflect trailing twelve months earnings where available.
Frequently Asked Questions
What is the largest Drug Manufacturers - General company? The largest Drug Manufacturers - General company by market capitalization is Eli Lilly and Company (LLY), valued at $949.47B. Use the full listing below to explore all Drug Manufacturers - General companies and compare their financials.
How many Drug Manufacturers - General stocks are there? There are 21 publicly traded Drug Manufacturers - General companies listed on major US exchanges, ranging from Eli Lilly and Company (LLY) to AstraZeneca PLC (AZN) by market capitalization. This directory spans 1 pages, with all companies sorted by market cap for easy comparison.
How many Drug Manufacturers - General stocks pay dividends? 15 of the 21 Drug Manufacturers - General companies (71%) currently distribute dividends. The average yield among payers is 3.07%. Dividend policies vary significantly across Drug Manufacturers - General companies — browse individual stock pages for the latest yield and payout details.
What is the average P/E ratio for Drug Manufacturers - General stocks? The average trailing P/E ratio for the Drug Manufacturers - General industry is 26.3x. Individual company valuations can vary widely — click through to any stock page for detailed valuation metrics.
Explore Drug Manufacturers - General Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 21 Drug Manufacturers - General companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - General stocks head to head. All data is updated regularly to reflect the latest available financials.